Results 151 to 160 of about 2,769 (201)

Rationale and Design of the CREATE Trial: A Multicenter, Randomized Comparison of Continuation or Cessation of Single Antithrombotic Therapy at 1 Year After Transcatheter Aortic Valve Replacement. [PDF]

J Am Heart Assoc
Liu R, Li Y, Zhang L, Lu Z, Fu Z, Modine T, Jilahawi H, Pocock S, Wu Y, Song G.   +9 more
europepmc   +1 more source

Berberine Targets PKM2 to Activate the t-PA-Induced Fibrinolytic System and Improves Thrombosis. [PDF]

Pharmaceuticals (Basel)
Sun Z, Zhao T, Bai X, Li H, Gao J, Hao Y, Li Y, Xie Y, Hu A, Huang Q, Liu X, Zhang Y.   +11 more
europepmc   +1 more source

Intravenous Thrombolysis to Dissolve Acute Stroke Thrombi: Reflections on the Past Decade. [PDF]

Stroke
Aziz YN, Khatri P.
europepmc   +1 more source

Current state of alpaca reproduction: present status and future perspectives of assisted reproductive technologies. [PDF]

Front Vet Sci
Landinez-Aponte J, Wang Z.
europepmc   +1 more source

Kringle-Dependent Inhibition of Plasmin-Mediated Fibrinolysis by Native and Citrullinated Core Histones. [PDF]

Int J Mol Sci
Komorowicz E, Gurabi A, Wacha A, Szabó L, Ozohanics O, Kolev K.   +5 more
europepmc   +1 more source

Plasminogen activation and plasmin activity are not necessary to prevent venous thrombosis/thromboembolism.

Blood
Sang Y, Menegatti M, Brody JA, Wiggins KL, Cooley BC, Kapfer KN, Kangro K, de Laat B, Peyvandi F, Flick MJ, Smith NL, Shapiro AD, Wolberg AS.   +12 more
europepmc   +1 more source

Fibrinolysin Treatment of Thromboembolism

JAMA - Journal of the American Medical Association, 1964
Fibrinolysin (Thrombolysin) has been used in various dosage schedules for thromboembolic disorders, but its clinical value has not been established. In this study, a single large intravenous dose was given at onset of anticoagulant therapy to 170 patients with thrombophlebitis, pulmonary embolism, or acute myocardial infarction.
Harold L Israel, D A Cooper
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Treatment of Total Hyphema with Fibrinolysin

JAMA Ophthalmology, 1963
I. Introduction In a previous paper 1 we reported the successful treatment of 2 eyes with traumatic total hyphema and secondary glaucoma by irrigation with fibrinolysin. The present paper reports data on 8 eyes treated by us and on 56 eyes submitted to us by other ophthalmologists.
Harold G Scheie, H G Scheie
exaly   +3 more sources

USE OF FIBRINOLYSIN IN SURGICAL COMPLICATIONS

Archives of Surgery, 1952
WE ARE presenting our experience with the enzymatic agent fibrinolysin in the treatment of several surgical complications. One hundred instances in which the material was used are reviewed in order to evaluate its worth. The proenzyme, profibrinolysin, occurs naturally and circulates in human and animal plasma.
R R, MARGULIS, B E, BRUSH
openaire   +3 more sources

Prothrombin and Fibrinolysin

Science, 1946
W H Seegers
exaly   +4 more sources